• Curious if GE HealthCare Technologies is more bargain or bubble at today’s price? You’re not alone, especially as investors look for real value in a complex market.
• GE HealthCare Technologies shares just jumped 10.8% over the past week, though the stock is still down 5.2% over the past year. This highlights both upside potential and wariness in the market.
• Recent headlines spotlight the company’s partnerships in digital health and AI-driven diagnostics, fueling excitement around its growth prospects. This surge of interest could be a sign the market is rethinking both the risks and rewards.
• On our six-point valuation check, GE HealthCare Technologies scores a 5. See the details here. This suggests it is undervalued by most measures. We’ll dig into what those approaches mean, and there may be a smarter way to understand this stock’s true value.

Approach 1: GE HealthCare Technologies Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow (DCF) model estimates a company’s intrinsic value by projecting its future cash flows and then discounting those forecasts back to today’s dollars. The result is an informed sense of what the business is truly worth, going beyond just its current stock price or earnings.

For GE HealthCare Technologies, the latest reported free cash flow stands at $1.43 billion. Analyst projections suggest this could more than double over the next decade, with free cash flow estimated at $2.84 billion in 2028 and reaching over $4 billion by 2035. For the first five years, these cash flow estimates are based on direct analyst forecasts. Further growth is projected by Simply Wall St using conservative industry trends and company performance.

The DCF model calculates an estimated intrinsic value per share of $124.48. This implies the stock is currently trading at a 37.1% discount to its fair value, suggesting it is significantly undervalued based on long-term cash generation potential.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests GE HealthCare Technologies is undervalued by 37.1%. Track this in your watchlist or portfolio, or discover 922 more undervalued stocks based on cash flows.

Approach 2: GE HealthCare Technologies Price vs Earnings

The Price-to-Earnings (PE) ratio is often the go-to valuation metric for profitable companies, like GE HealthCare Technologies, because it directly relates a company’s market price to its bottom-line earnings. For investors, a company’s PE ratio provides a simple way to gauge how much they’re paying for each dollar of profit the business earns.

What counts as a “normal” or “fair” PE ratio is shaped by a few core factors. Companies with strong growth prospects or lower risk usually justify higher PE ratios, while those with uncertain outlooks or industry headwinds tend to trade at lower ones.

GE HealthCare Technologies currently trades at a PE ratio of 16.1x. That is notably lower than the Medical Equipment industry average of 28.2x and the average of its listed peers at 33.0x. On the surface, this looks like a deep discount to the sector and its competitors.

Simply Wall St’s proprietary “Fair Ratio” gives a more tailored benchmark. This metric, set at 26.3x for GE HealthCare Technologies, takes into account the company’s unique earnings growth outlook, profit margin, size in the market, and specific industry dynamics, in addition to its risks. That is why it is considered more reliable than comparing with blunt peer or industry averages, which overlook growth and risk nuances.

With GE HealthCare Technologies’ current PE at 16.1x and its Fair Ratio at 26.3x, the stock appears undervalued on this measure, pointing toward potential upside if the company can deliver on its expected performance.

Result: UNDERVALUED

PE ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1434 companies where insiders are betting big on explosive growth.

Upgrade Your Decision Making: Choose your GE HealthCare Technologies Narrative

Earlier we mentioned that there is an even better way to understand valuation. Let us introduce you to Narratives. Narratives offer an approachable framework for investing by letting you articulate your story or perspective on a company, such as how you see its future revenue, earnings, and margins playing out, so you can connect that story directly to financial forecasts and a fair value estimate. By combining your view of GE HealthCare Technologies’ business outlook with transparent, customizable forecasts, Narratives bridge the gap between numbers and real-world events. This approach gives richer context for decisions about when to buy or sell, based on the difference between Fair Value and today’s Price.

Millions of investors use Narratives in the Simply Wall St Community page, where updates occur dynamically as news or earnings emerge, ensuring your analysis reflects the latest shifts. For example, some investors may craft a bullish Narrative, expecting innovations and order backlog to deliver strong future earnings and set a fair value as high as $106. Others, who are more cautious due to regulatory and China market risks, may argue for a more conservative fair value closer to $73.

Do you think there's more to the story for GE HealthCare Technologies? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.